What's New in Muscular Dystrophy?

A Quarterly Webinar Series for Patients and Families

Join Kevin Flanigan, MD, and his guests for What’s New in Muscular Dystrophy?, a webinar series that highlights the latest in basic and clinical research at Nationwide Children's Hospital.  Learn about new and exciting findings and what this work might mean for the treatment of muscular dystrophies and other inherited neuromuscular disorders.

Register by Friday, March 26, at 2 p.m. to receive an invitation to join the webinar on March 27.

Saturday, March 27, 2021 (2 p.m.): “Preclinical development of vectorized exon 44 skipping” featuring Dr. Nicolas Wein

Nationwide Children's Hospital Medical Professional

Featured Speaker
Nicolas Wein, PhD
Principal Investigator, Center for Gene Therapy

Nicolas Wein, PhD, is a principal investigator in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor of Pediatrics at The Ohio State University College of Medicine.

Dr. Wein and his lab in study neuromuscular disorders, particularly Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1), to understand their causes and develop innovative treatments.

Register to Join